Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Anthony P. Y. Liu, Kyle Smith, Rahul Kumar, Leena Paul, Laure Bihannic, Tong Lin, Kendra K. Maaß, Kristian W. Pajtler, Murali Chintagumpala, Jack M. Su, Éric Bouffet, Michael J. Fisher, Sridharan Gururangan, Richard J. Cohn, Tim Hassall, Jordan R. Hansford, Paul Klimo, Frederick A. Boop, Clinton F. Stewart, Julie H. Harreld, Thomas E. Merchant, Ruth Tatevossian, Geoffrey Neale, Matthew Lear, Jeffery M. Klco, Brent A. Orr, David W. Ellison, Richard J. Gilbertson, Arzu Onar‐Thomas, Amar Gajjar, Giles Robinson, Paul A. Northcott
Topics & Concepts
MedulloblastomaMedicineMinimal residual diseaseBiomarkerOncologyLiquid biopsyInternal medicineProspective cohort studyCerebrospinal fluidSurrogate endpointPathologyCancerBiologyBone marrowBiochemistryCancer Genomics and DiagnosticsGlioma Diagnosis and TreatmentSingle-cell and spatial transcriptomics